At Phenomic, we are pioneers in using advanced machine learning tools for processing imaging and RNA sequencing data. By leveraging these tools to deconvolute the effects of target inhibition on single-cells in complex models, we are able to rapidly identify and target novel cell-cell interactions that are driving the disease, and map results back to human biology.